Synthesis and Biological Evaluation of A Series of (Benzo[d]thiazol-2-yl)cyclohexanecarboxamides and (Benzo[d]thiazol-2-yl)cyclohexanecarbothioamides

Med Chem. 2010 May;6(3):159-64. doi: 10.2174/1573406411006030159.

Abstract

A series of benzothiazole derivatives including N-(benzo[d]thiazol-2-yl)cyclohexanecarboxamides (2a-g) and N-(benzo[d]thiazol-2-yl)cyclohexancarbothioamides (3b-d) have been synthesized and evaluated for cytotoxic and antimicrobial activities. Two compounds including N-(6-ethoxybenzo[d]thiazol-2-yl)cyclohexanecarboxamide (2c) and N-(6-ethoxybenzo[d]thiazol-2-yl)cyclohexanecarbothiamide (3c) demonstrated significant cytotoxicity against three cancer cell lines (A549, MCF7-MDR and HT1080) while most of compounds exhibited moderate inhibitory effects on the growth of Staphyllococcus aureus and some other fungi.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Infective Agents / chemical synthesis
  • Anti-Infective Agents / pharmacology
  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / pharmacology
  • Aspergillus niger / drug effects
  • Bacillus subtilis / drug effects
  • Benzothiazoles / chemical synthesis*
  • Benzothiazoles / pharmacology*
  • Candida albicans / drug effects
  • Cell Line, Tumor
  • Cell Proliferation / drug effects*
  • Drug Evaluation, Preclinical
  • Escherichia coli / drug effects
  • Fusarium / drug effects
  • Humans
  • Inhibitory Concentration 50
  • Microbial Sensitivity Tests
  • Pseudomonas aeruginosa / drug effects
  • Saccharomyces cerevisiae / drug effects
  • Staphylococcus aureus / drug effects*

Substances

  • Anti-Infective Agents
  • Antineoplastic Agents
  • Benzothiazoles
  • N-(6-ethoxybenzo(d)thiazol-2-yl)cyclohexanecarbothiamide
  • N-(6-ethoxybenzo(d)thiazol-2-yl)cyclohexanecarboxamide